Pentamidine Isethionate Injection, Powder, Lyophilized, For Solution
Product Images NDC 13925-515

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentamidine Isethionate (NDC 13925-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Seton Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label

FDA Label Image

Pentam-structure (Cb8e8155 5505 44d5 9dee 525e2e45b95d 01)

FDA Label Image

Vial Label

Vial Label
This is a description of a medication in the form of a lyophilized and sterile injection, containing Petomidine Setionae and Penta_n'lldlne. It is a preservative-free product and should be protected from light. The package insert recommends reconstituting it with sterile water for injection or 5% Dextrose Injection, as directed. The product is manufactured by Seonoo US and is intended for single use only. The net content of the vial is 300mg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.